![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Biofer Spa Milano It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Methylprednisolone hydrogen succinate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2019-312 - Rev 01
This Chemical Type CEP, issued on April 20, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1131 associated with this CEP further emphasizes